---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-061936"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2025-07-08T23:59:59+00:00"
generated_at: "2026-05-18T09:07:21.349479+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Unicycive regains Nasdaq minimum bid price compliance after reverse split

## Summary
- Regained compliance with Nasdaq minimum bid price of $1.00 per share.
- Nasdaq notified the company on July 7, 2025, confirming compliance as of July 3, 2025.
- Compliance achieved after a 1:10 reverse stock split effective June 20, 2025.
- The matter is now closed by Nasdaq.

## SEC filing metadata
- accession: 0001213900-25-061936
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2025-07-08T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390025061936/0001213900-25-061936-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390025061936/ea0248322-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-061936
- JSON: https://secwatch.observer/filing/0001213900-25-061936.json
- Plain text: https://secwatch.observer/filing/0001213900-25-061936.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.